Hormones Diabetes Management Hormonal Disorders Thyroid Disorders Hormonal Treatments Diabetes Insulin Therapy Hormonal Therapies Hormone Therapy Weight Management Metabolic Disorders Insulin Management Polycystic Ovary Syndrome Gut Hormones Endocrinologists Hypothyroidism Insulin Delivery Systems Hypoglycemia Osteoporosis Hormonal Implants Hormonal Changes Gene Expression Gender Dysphoria Treatment Thyroid Diseases Adrenal Gland Disorders Thyroid Function Metabolic Health Growth Disorders Metabolism Adrenal Glands Neuroendocrinology Pediatric Endocrinology Hypoparathyroidism Hormone Therapies Neuroendocrine Disorders Insulin Resistance Thyroid Conditions Thyroid Obesity Treatment Thyroid Health Insulin Testosterone Therapy Hypertension GLP-1 Receptor Agonists Hormonal Regulation Pancreatic Disorders Blood Sugar Regulation Diabetes Treatment Thyroid Physiology
Want to see what podcasts are saying about this topic? Search across 135K+ podcasts. Explore Radar
The agency cleared the label on Aug. 28, 2026 after Lilly’s head‑to‑head SURPASS‑CVOT showed a modest cardiovascular advantage over Trulicity, a result that broadens Mounjaro’s clinical and commercial role.
